v3.26.1
Consolidated Statements of Changes in Equity and Shareholders' Equity (Deficit) - USD ($)
Common Stock
Public Offering
Common Stock
Pre-funded warrants
Common Stock
Existing Warrants
Common Stock
New warrants
Common Stock
Additional Paid-In Capital
Public Offering
Additional Paid-In Capital
At Market Issuance Sales Agreement
Additional Paid-In Capital
Pre-funded warrants
Additional Paid-In Capital
Existing Warrants
Additional Paid-In Capital
New warrants
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Public Offering
At Market Issuance Sales Agreement
Pre-funded warrants
Existing Warrants
New warrants
Total
Balance at Dec. 31, 2023         $ 649           $ 228,203,706 $ 22,243 $ (225,704,176)           $ 2,522,422
Balance (in shares) at Dec. 31, 2023         648,761                            
Issuance of common stock pursuant to At Market Issuance Sales Agreement         $ 229           1,071,330               1,071,559
Issuance of common stock pursuant to At Market Issuance Sales Agreement (in shares) 204,694       229,078                            
Issuance costs           $ (625,065) $ (24,484)             $ (625,065) $ (24,484)        
Issuance of common stock and pre-funded warrants in connection with public offering         $ 205           4,741,195               4,741,400
Issuance of common stock and pre-funded warrants in connection with public offering (in shares)         204,694                            
Issuance of common stock to vendors         $ 5           15,795               $ 15,800
Issuance of common stock to vendors (in shares)         5,000                           5,000
Fractional shares issued in June 2024 reverse stock split         $ 115           (115)                
Fractional shares issued in June 2024 reverse stock split (in shares)         114,735                            
Issuance of common stock upon exercise of warrants   $ 537 $ 703 $ 35       $ 8,063 $ 4,218,047 $ 222,787           $ 8,600 $ 4,218,750 $ 222,822  
Issuance of common stock upon exercise of warrant   537,500 703,125 34,816                           34,816  
Issuance costs associated with warrant inducement                     (7,552,457)               $ (7,552,457)
Warrant modification - incremental fair value                     7,177,683               7,177,683
Issuance of common stock from conversion of debt         $ 36           254,220               254,256
Issuance of common stock from conversion of debt (in shares)         36,790                            
Share-based compensation expense                     329,815               329,815
Foreign currency translation adjustment                       23,546             23,546
Net loss                         (8,266,576)           (8,266,576)
Balance at Dec. 31, 2024         $ 2,514           238,040,520 45,789 (233,970,752)           $ 4,118,071
Balance (in shares) at Dec. 31, 2024         2,514,499                           2,514,499
Issuance of common stock pursuant to At Market Issuance Sales Agreement         $ 1,760           4,664,661               $ 4,666,421
Issuance of common stock pursuant to At Market Issuance Sales Agreement (in shares)         1,758,725                 4,064,080          
Issuance costs           $ (776,086) $ (103,847)             $ (776,086) $ (103,847)        
Issuance of common stock and pre-funded warrants in connection with public offering         $ 4,064           7,494,458               7,498,522
Issuance of common stock and pre-funded warrants in connection with public offering (in shares)         4,064,080                            
Issuance of common stock to vendors         $ 32           76,568               $ 76,600
Issuance of common stock to vendors (in shares)         32,346                           32,346
Issuance of common stock upon exercise of warrants   $ 1,491   $ 225           $ 303,525           $ 1,491   $ 303,750  
Issuance of common stock upon exercise of warrant   1,491,480   225,000                             225,000
Share-based compensation expense                     587,583               $ 587,583
Net loss                         (11,080,380)           (11,080,380)
Balance at Dec. 31, 2025         $ 10,086           $ 250,287,382 $ 45,789 $ (245,051,132)           $ 5,292,125
Balance (in shares) at Dec. 31, 2025         10,086,130                           10,086,130